Quote:

---

I saw that too. My reaction was the opposite- that including intubated patients may provide a greater delta between treatment and placebo - giving us a better p value.

---

Yeah, I didn't know which side of the fence to fall on. In the end, I decided that the leronlimab arm having absolutely NO mortality might provide the best P-value and optics. But, of course, I could be wrong.